Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2′-deoxycytidine level in cultured cancerous cell lines
Authors:
Open Access
- 30 November 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (11) , e0188856
Abstract
Active demethylation of 5-methylcytosine moiety in DNA occurs by its sequential oxidation to 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxycytosine, catalysed by enzymes of the Ten-Eleven Translocation family proteins (TETs 1, 2 and 3). Here we analyzed for the first time all the intermediate products of DNA demethylation pathway in the form of deoxynucleosides (5-methyl-2′-deoxycytidine, 5-(hydroxymethyl)-2′-deoxycytidine, 5-formyl-2′-deoxycytidine and 5-carboxy-2′-deoxycytidine as well as 5-(hydroxymethyl)-2′-deoxyuridine) using automated isotope-dilution online two-dimensional ultra-performance liquid chromatography with tandem mass spectrometry. DNA was isolated from human malignant cell lines of colon adenocarcinoma (HCT 116), melanoma (Me45), myelogenous leukemia bone marrow blasts (K562), EBV-positive Burkitt’s lymphoma lymphoblasts (Raji), EBV-negative Burkitt’s lymphoma lymphoblasts (male-CA46 and female-ST486), as well as normal neonatal dermal fibroblasts (NHDF-Neo). The expression levels of TET1, TET2, TET3, SMUG1, and TDG genes were also assayed by RT-qPCR. Our results show a global erasure of 5-hydroxymethyl-2′-deoxycytidine and 5-carboxy-2′-deoxycytidine in DNA of cultured cells compared with DNA from primary malignant tissue. Moreover, malignant cells in culture have a quite different DNA epigenetic profile than cultured normal cells, and different types of malignant cells display different and characteristic profiles of DNA epigenetic marks. Similar analyses of a broader spectrum of epigenetic modifications, not restricted to 5-methyl-2′-deoxycytidine, could lead to better understanding of the mechanism(s) responsible for emergence of different types of cancer cells.Keywords
Funding Information
- Polish National Science Center (https://www.ncn.gov.pl/) (DEC-2012/07/B/NZ1/00008)
- Polish National Science Center (https://www.ncn.gov.pl/) (DEC-2015/19/B/NZ5/02208)
This publication has 46 references indexed in Scilit:
- Reversing DNA Methylation: Mechanisms, Genomics, and Biological FunctionsCell, 2014
- Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized DerivativesCell, 2013
- Dynamic DNA methylation across diverse human cell lines and tissuesGenome Research, 2013
- Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genesGenome Research, 2011
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistanceProceedings of the National Academy of Sciences, 2011
- The Curious Chemical Biology of Cytosine: Deamination, Methylation,and Oxidation as Modulators of Genomic PotentialACS Chemical Biology, 2011
- Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation IntermediatesPLOS ONE, 2010
- Epigenetic Reprogramming in Plant and Animal DevelopmentScience, 2010
- Spectroscopic properties and photodynamic effects of new lipophilic porphyrin derivatives: Efficacy, localisation and cell death pathwaysJournal of Photochemistry and Photobiology B: Biology, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001